Global Rhodiola Root Market

Rhodiola Root Comprehensive Study by Application (Altitude Sickness, Bladder Cancer, Depression, Fatigue, Other Applications), End User (Dietary Supplements, Cosmetics, Pharmaceuticals, Other), Nature (Organic, Conventional), Dosage Form (Liquid, Powder) Players and Region - Global Market Outlook to 2030

Rhodiola Root Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 8.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Rhodiola Root
Rhodiola root is also known as golden root, western roseroot, Aaron's rod, rose root, Arctic root, king's crown, lignum rhodium, or orpin rose. It is a perennial flowering plant in the family Crassulaceae. The rhodiola root is widely used for medical use as it helps in reducing the depression, stirring the nervous system, and increase physical endurance. Rhodiola root helps to increase stamina, concentration, and mental well-being. The uses of Rhodiola in mild to moderate depression and generalized anxiety has increased and this is expected to drive their demand in upcoming years.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR8.9%


In Rhodiola Root Market, it has been observed that most of the companies are upgrading or introducing innovative products. They rely on strategies such as mergers & acquisitions, product development, geographical expansion, technological innovation and sourcing strategies to enhance their market share. Analyst at AMA Research estimates that Global Vendors will contribute the maximum growth to Global Rhodiola Root market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

NutraChamps Inc. (Canada), Organic Herb Inc. (China), Amax NutraSource (United States), Xian Yuensun Biological Technology Co.,Ltd. (China), PLT Health Solutions, Inc. (United States), Xi’an Greena Biotech Co.,Ltd. (China), Swanson Health Products (United States), Planetary Herbals (United States), Gaia Herbs, LLC (United States) and Nutracraft (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Rhodiola Root market by , Application (Altitude Sickness, Bladder Cancer, Depression, Fatigue and Other Applications) and Region.



On the basis of geography, the market of Rhodiola Root has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User , the sub-segment i.e. Dietary Supplements will boost the Rhodiola Root market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Nature , the sub-segment i.e. Organic will boost the Rhodiola Root market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Dosage Form , the sub-segment i.e. Liquid will boost the Rhodiola Root market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Use of Rhodiola Root in Asian Countries

Market Growth Drivers:
Increasing Use for Medical Purpose and Growing Use as Dietary Supplement

Restraints:
May Led to Side Effects Such as Allergy, Irritability, And Insomnia

Opportunities:
Improving Athletic Performance and Increasing Use in Folk Medicine as Ethanolic Macerates

Market Leaders and their expansionary development strategies
In April 2023, PLT Health Solutions, Inc announced that it has begun offering CITES-compliant Rhodiolife Rhodiola rosea in North America. This new development will assure its Rhodiola customers a secure supply of a premium, highly sustainable product that meets all regulatory requirements.
In March 2024, Gnosis by Lesaffre has announced the launch of a natural energy solution called Landkind Pure Salidroside. Salidroside is the most studied bioactive in Rhodiola rosea or Rhodiola crenulate, with over 680 scientific papers on Pubmed, explains the company in a press release. The company’s Pure Salidroside is isolated using its proprietary fermentation process.


Key Target Audience
Rhodiola Root Manufacturers, Traders, Importers, and Exporters, Raw Material Suppliers and Distributors, Research and Consulting Firms, Government and Research Organizations and Associations and Industry Bodies

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Altitude Sickness
  • Bladder Cancer
  • Depression
  • Fatigue
  • Other Applications
By End User
  • Dietary Supplements
  • Cosmetics
  • Pharmaceuticals
  • Other

By Nature
  • Organic
  • Conventional

By Dosage Form
  • Liquid
  • Powder

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Use for Medical Purpose
      • 3.2.2. Growing Use as Dietary Supplement
    • 3.3. Market Trends
      • 3.3.1. Growing Use of Rhodiola Root in Asian Countries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Rhodiola Root, by Application, End User , Nature , Dosage Form and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Rhodiola Root (Value)
      • 5.2.1. Global Rhodiola Root by: Application (Value)
        • 5.2.1.1. Altitude Sickness
        • 5.2.1.2. Bladder Cancer
        • 5.2.1.3. Depression
        • 5.2.1.4. Fatigue
        • 5.2.1.5. Other Applications
      • 5.2.2. Global Rhodiola Root Region
        • 5.2.2.1. South America
          • 5.2.2.1.1. Brazil
          • 5.2.2.1.2. Argentina
          • 5.2.2.1.3. Rest of South America
        • 5.2.2.2. Asia Pacific
          • 5.2.2.2.1. China
          • 5.2.2.2.2. Japan
          • 5.2.2.2.3. India
          • 5.2.2.2.4. South Korea
          • 5.2.2.2.5. Taiwan
          • 5.2.2.2.6. Australia
          • 5.2.2.2.7. Rest of Asia-Pacific
        • 5.2.2.3. Europe
          • 5.2.2.3.1. Germany
          • 5.2.2.3.2. France
          • 5.2.2.3.3. Italy
          • 5.2.2.3.4. United Kingdom
          • 5.2.2.3.5. Netherlands
          • 5.2.2.3.6. Rest of Europe
        • 5.2.2.4. MEA
          • 5.2.2.4.1. Middle East
          • 5.2.2.4.2. Africa
        • 5.2.2.5. North America
          • 5.2.2.5.1. United States
          • 5.2.2.5.2. Canada
          • 5.2.2.5.3. Mexico
    • 5.3. Global Rhodiola Root (Volume)
      • 5.3.1. Global Rhodiola Root by: Application (Volume)
        • 5.3.1.1. Altitude Sickness
        • 5.3.1.2. Bladder Cancer
        • 5.3.1.3. Depression
        • 5.3.1.4. Fatigue
        • 5.3.1.5. Other Applications
      • 5.3.2. Global Rhodiola Root Region
        • 5.3.2.1. South America
          • 5.3.2.1.1. Brazil
          • 5.3.2.1.2. Argentina
          • 5.3.2.1.3. Rest of South America
        • 5.3.2.2. Asia Pacific
          • 5.3.2.2.1. China
          • 5.3.2.2.2. Japan
          • 5.3.2.2.3. India
          • 5.3.2.2.4. South Korea
          • 5.3.2.2.5. Taiwan
          • 5.3.2.2.6. Australia
          • 5.3.2.2.7. Rest of Asia-Pacific
        • 5.3.2.3. Europe
          • 5.3.2.3.1. Germany
          • 5.3.2.3.2. France
          • 5.3.2.3.3. Italy
          • 5.3.2.3.4. United Kingdom
          • 5.3.2.3.5. Netherlands
          • 5.3.2.3.6. Rest of Europe
        • 5.3.2.4. MEA
          • 5.3.2.4.1. Middle East
          • 5.3.2.4.2. Africa
        • 5.3.2.5. North America
          • 5.3.2.5.1. United States
          • 5.3.2.5.2. Canada
          • 5.3.2.5.3. Mexico
    • 5.4. Global Rhodiola Root (Price)
  • 6. Rhodiola Root: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. NutraChamps Inc. (Canada)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Organic Herb Inc. (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Amax NutraSource (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Xian Yuensun Biological Technology Co.,Ltd. (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. PLT Health Solutions, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Xi’an Greena Biotech Co.,Ltd. (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Swanson Health Products (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Planetary Herbals (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Gaia Herbs, LLC (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Nutracraft (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Rhodiola Root Sale, by Application, End User , Nature , Dosage Form and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Rhodiola Root (Value)
      • 7.2.1. Global Rhodiola Root by: Application (Value)
        • 7.2.1.1. Altitude Sickness
        • 7.2.1.2. Bladder Cancer
        • 7.2.1.3. Depression
        • 7.2.1.4. Fatigue
        • 7.2.1.5. Other Applications
      • 7.2.2. Global Rhodiola Root Region
        • 7.2.2.1. South America
          • 7.2.2.1.1. Brazil
          • 7.2.2.1.2. Argentina
          • 7.2.2.1.3. Rest of South America
        • 7.2.2.2. Asia Pacific
          • 7.2.2.2.1. China
          • 7.2.2.2.2. Japan
          • 7.2.2.2.3. India
          • 7.2.2.2.4. South Korea
          • 7.2.2.2.5. Taiwan
          • 7.2.2.2.6. Australia
          • 7.2.2.2.7. Rest of Asia-Pacific
        • 7.2.2.3. Europe
          • 7.2.2.3.1. Germany
          • 7.2.2.3.2. France
          • 7.2.2.3.3. Italy
          • 7.2.2.3.4. United Kingdom
          • 7.2.2.3.5. Netherlands
          • 7.2.2.3.6. Rest of Europe
        • 7.2.2.4. MEA
          • 7.2.2.4.1. Middle East
          • 7.2.2.4.2. Africa
        • 7.2.2.5. North America
          • 7.2.2.5.1. United States
          • 7.2.2.5.2. Canada
          • 7.2.2.5.3. Mexico
    • 7.3. Global Rhodiola Root (Volume)
      • 7.3.1. Global Rhodiola Root by: Application (Volume)
        • 7.3.1.1. Altitude Sickness
        • 7.3.1.2. Bladder Cancer
        • 7.3.1.3. Depression
        • 7.3.1.4. Fatigue
        • 7.3.1.5. Other Applications
      • 7.3.2. Global Rhodiola Root Region
        • 7.3.2.1. South America
          • 7.3.2.1.1. Brazil
          • 7.3.2.1.2. Argentina
          • 7.3.2.1.3. Rest of South America
        • 7.3.2.2. Asia Pacific
          • 7.3.2.2.1. China
          • 7.3.2.2.2. Japan
          • 7.3.2.2.3. India
          • 7.3.2.2.4. South Korea
          • 7.3.2.2.5. Taiwan
          • 7.3.2.2.6. Australia
          • 7.3.2.2.7. Rest of Asia-Pacific
        • 7.3.2.3. Europe
          • 7.3.2.3.1. Germany
          • 7.3.2.3.2. France
          • 7.3.2.3.3. Italy
          • 7.3.2.3.4. United Kingdom
          • 7.3.2.3.5. Netherlands
          • 7.3.2.3.6. Rest of Europe
        • 7.3.2.4. MEA
          • 7.3.2.4.1. Middle East
          • 7.3.2.4.2. Africa
        • 7.3.2.5. North America
          • 7.3.2.5.1. United States
          • 7.3.2.5.2. Canada
          • 7.3.2.5.3. Mexico
    • 7.4. Global Rhodiola Root (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Rhodiola Root: by Application(USD Million)
  • Table 2. Rhodiola Root Altitude Sickness , by Region USD Million (2018-2023)
  • Table 3. Rhodiola Root Bladder Cancer , by Region USD Million (2018-2023)
  • Table 4. Rhodiola Root Depression , by Region USD Million (2018-2023)
  • Table 5. Rhodiola Root Fatigue , by Region USD Million (2018-2023)
  • Table 6. Rhodiola Root Other Applications , by Region USD Million (2018-2023)
  • Table 7. South America Rhodiola Root, by Country USD Million (2018-2023)
  • Table 8. South America Rhodiola Root, by Application USD Million (2018-2023)
  • Table 9. South America Rhodiola Root, by End User USD Million (2018-2023)
  • Table 10. South America Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 11. South America Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 12. Brazil Rhodiola Root, by Application USD Million (2018-2023)
  • Table 13. Brazil Rhodiola Root, by End User USD Million (2018-2023)
  • Table 14. Brazil Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 15. Brazil Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 16. Argentina Rhodiola Root, by Application USD Million (2018-2023)
  • Table 17. Argentina Rhodiola Root, by End User USD Million (2018-2023)
  • Table 18. Argentina Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 19. Argentina Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 20. Rest of South America Rhodiola Root, by Application USD Million (2018-2023)
  • Table 21. Rest of South America Rhodiola Root, by End User USD Million (2018-2023)
  • Table 22. Rest of South America Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 23. Rest of South America Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 24. Asia Pacific Rhodiola Root, by Country USD Million (2018-2023)
  • Table 25. Asia Pacific Rhodiola Root, by Application USD Million (2018-2023)
  • Table 26. Asia Pacific Rhodiola Root, by End User USD Million (2018-2023)
  • Table 27. Asia Pacific Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 28. Asia Pacific Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 29. China Rhodiola Root, by Application USD Million (2018-2023)
  • Table 30. China Rhodiola Root, by End User USD Million (2018-2023)
  • Table 31. China Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 32. China Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 33. Japan Rhodiola Root, by Application USD Million (2018-2023)
  • Table 34. Japan Rhodiola Root, by End User USD Million (2018-2023)
  • Table 35. Japan Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 36. Japan Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 37. India Rhodiola Root, by Application USD Million (2018-2023)
  • Table 38. India Rhodiola Root, by End User USD Million (2018-2023)
  • Table 39. India Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 40. India Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 41. South Korea Rhodiola Root, by Application USD Million (2018-2023)
  • Table 42. South Korea Rhodiola Root, by End User USD Million (2018-2023)
  • Table 43. South Korea Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 44. South Korea Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 45. Taiwan Rhodiola Root, by Application USD Million (2018-2023)
  • Table 46. Taiwan Rhodiola Root, by End User USD Million (2018-2023)
  • Table 47. Taiwan Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 48. Taiwan Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 49. Australia Rhodiola Root, by Application USD Million (2018-2023)
  • Table 50. Australia Rhodiola Root, by End User USD Million (2018-2023)
  • Table 51. Australia Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 52. Australia Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 53. Rest of Asia-Pacific Rhodiola Root, by Application USD Million (2018-2023)
  • Table 54. Rest of Asia-Pacific Rhodiola Root, by End User USD Million (2018-2023)
  • Table 55. Rest of Asia-Pacific Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 56. Rest of Asia-Pacific Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 57. Europe Rhodiola Root, by Country USD Million (2018-2023)
  • Table 58. Europe Rhodiola Root, by Application USD Million (2018-2023)
  • Table 59. Europe Rhodiola Root, by End User USD Million (2018-2023)
  • Table 60. Europe Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 61. Europe Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 62. Germany Rhodiola Root, by Application USD Million (2018-2023)
  • Table 63. Germany Rhodiola Root, by End User USD Million (2018-2023)
  • Table 64. Germany Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 65. Germany Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 66. France Rhodiola Root, by Application USD Million (2018-2023)
  • Table 67. France Rhodiola Root, by End User USD Million (2018-2023)
  • Table 68. France Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 69. France Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 70. Italy Rhodiola Root, by Application USD Million (2018-2023)
  • Table 71. Italy Rhodiola Root, by End User USD Million (2018-2023)
  • Table 72. Italy Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 73. Italy Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 74. United Kingdom Rhodiola Root, by Application USD Million (2018-2023)
  • Table 75. United Kingdom Rhodiola Root, by End User USD Million (2018-2023)
  • Table 76. United Kingdom Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 77. United Kingdom Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 78. Netherlands Rhodiola Root, by Application USD Million (2018-2023)
  • Table 79. Netherlands Rhodiola Root, by End User USD Million (2018-2023)
  • Table 80. Netherlands Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 81. Netherlands Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 82. Rest of Europe Rhodiola Root, by Application USD Million (2018-2023)
  • Table 83. Rest of Europe Rhodiola Root, by End User USD Million (2018-2023)
  • Table 84. Rest of Europe Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 85. Rest of Europe Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 86. MEA Rhodiola Root, by Country USD Million (2018-2023)
  • Table 87. MEA Rhodiola Root, by Application USD Million (2018-2023)
  • Table 88. MEA Rhodiola Root, by End User USD Million (2018-2023)
  • Table 89. MEA Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 90. MEA Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 91. Middle East Rhodiola Root, by Application USD Million (2018-2023)
  • Table 92. Middle East Rhodiola Root, by End User USD Million (2018-2023)
  • Table 93. Middle East Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 94. Middle East Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 95. Africa Rhodiola Root, by Application USD Million (2018-2023)
  • Table 96. Africa Rhodiola Root, by End User USD Million (2018-2023)
  • Table 97. Africa Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 98. Africa Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 99. North America Rhodiola Root, by Country USD Million (2018-2023)
  • Table 100. North America Rhodiola Root, by Application USD Million (2018-2023)
  • Table 101. North America Rhodiola Root, by End User USD Million (2018-2023)
  • Table 102. North America Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 103. North America Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 104. United States Rhodiola Root, by Application USD Million (2018-2023)
  • Table 105. United States Rhodiola Root, by End User USD Million (2018-2023)
  • Table 106. United States Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 107. United States Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 108. Canada Rhodiola Root, by Application USD Million (2018-2023)
  • Table 109. Canada Rhodiola Root, by End User USD Million (2018-2023)
  • Table 110. Canada Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 111. Canada Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 112. Mexico Rhodiola Root, by Application USD Million (2018-2023)
  • Table 113. Mexico Rhodiola Root, by End User USD Million (2018-2023)
  • Table 114. Mexico Rhodiola Root, by Nature USD Million (2018-2023)
  • Table 115. Mexico Rhodiola Root, by Dosage Form USD Million (2018-2023)
  • Table 116. Rhodiola Root Sales: by Application(Tons)
  • Table 117. Rhodiola Root Sales Altitude Sickness , by Region Tons (2018-2023)
  • Table 118. Rhodiola Root Sales Bladder Cancer , by Region Tons (2018-2023)
  • Table 119. Rhodiola Root Sales Depression , by Region Tons (2018-2023)
  • Table 120. Rhodiola Root Sales Fatigue , by Region Tons (2018-2023)
  • Table 121. Rhodiola Root Sales Other Applications , by Region Tons (2018-2023)
  • Table 122. South America Rhodiola Root Sales, by Country Tons (2018-2023)
  • Table 123. South America Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 124. South America Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 125. South America Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 126. South America Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 127. Brazil Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 128. Brazil Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 129. Brazil Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 130. Brazil Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 131. Argentina Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 132. Argentina Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 133. Argentina Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 134. Argentina Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 135. Rest of South America Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 136. Rest of South America Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 137. Rest of South America Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 138. Rest of South America Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 139. Asia Pacific Rhodiola Root Sales, by Country Tons (2018-2023)
  • Table 140. Asia Pacific Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 141. Asia Pacific Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 142. Asia Pacific Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 143. Asia Pacific Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 144. China Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 145. China Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 146. China Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 147. China Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 148. Japan Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 149. Japan Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 150. Japan Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 151. Japan Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 152. India Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 153. India Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 154. India Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 155. India Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 156. South Korea Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 157. South Korea Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 158. South Korea Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 159. South Korea Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 160. Taiwan Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 161. Taiwan Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 162. Taiwan Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 163. Taiwan Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 164. Australia Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 165. Australia Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 166. Australia Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 167. Australia Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 168. Rest of Asia-Pacific Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 169. Rest of Asia-Pacific Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 170. Rest of Asia-Pacific Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 171. Rest of Asia-Pacific Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 172. Europe Rhodiola Root Sales, by Country Tons (2018-2023)
  • Table 173. Europe Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 174. Europe Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 175. Europe Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 176. Europe Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 177. Germany Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 178. Germany Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 179. Germany Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 180. Germany Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 181. France Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 182. France Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 183. France Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 184. France Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 185. Italy Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 186. Italy Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 187. Italy Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 188. Italy Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 189. United Kingdom Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 190. United Kingdom Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 191. United Kingdom Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 192. United Kingdom Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 193. Netherlands Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 194. Netherlands Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 195. Netherlands Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 196. Netherlands Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 197. Rest of Europe Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 198. Rest of Europe Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 199. Rest of Europe Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 200. Rest of Europe Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 201. MEA Rhodiola Root Sales, by Country Tons (2018-2023)
  • Table 202. MEA Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 203. MEA Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 204. MEA Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 205. MEA Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 206. Middle East Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 207. Middle East Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 208. Middle East Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 209. Middle East Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 210. Africa Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 211. Africa Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 212. Africa Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 213. Africa Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 214. North America Rhodiola Root Sales, by Country Tons (2018-2023)
  • Table 215. North America Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 216. North America Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 217. North America Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 218. North America Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 219. United States Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 220. United States Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 221. United States Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 222. United States Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 223. Canada Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 224. Canada Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 225. Canada Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 226. Canada Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 227. Mexico Rhodiola Root Sales, by Application Tons (2018-2023)
  • Table 228. Mexico Rhodiola Root Sales, by End User Tons (2018-2023)
  • Table 229. Mexico Rhodiola Root Sales, by Nature Tons (2018-2023)
  • Table 230. Mexico Rhodiola Root Sales, by Dosage Form Tons (2018-2023)
  • Table 231. Company Basic Information, Sales Area and Its Competitors
  • Table 232. Company Basic Information, Sales Area and Its Competitors
  • Table 233. Company Basic Information, Sales Area and Its Competitors
  • Table 234. Company Basic Information, Sales Area and Its Competitors
  • Table 235. Company Basic Information, Sales Area and Its Competitors
  • Table 236. Company Basic Information, Sales Area and Its Competitors
  • Table 237. Company Basic Information, Sales Area and Its Competitors
  • Table 238. Company Basic Information, Sales Area and Its Competitors
  • Table 239. Company Basic Information, Sales Area and Its Competitors
  • Table 240. Company Basic Information, Sales Area and Its Competitors
  • Table 241. Rhodiola Root: by Application(USD Million)
  • Table 242. Rhodiola Root Altitude Sickness , by Region USD Million (2025-2030)
  • Table 243. Rhodiola Root Bladder Cancer , by Region USD Million (2025-2030)
  • Table 244. Rhodiola Root Depression , by Region USD Million (2025-2030)
  • Table 245. Rhodiola Root Fatigue , by Region USD Million (2025-2030)
  • Table 246. Rhodiola Root Other Applications , by Region USD Million (2025-2030)
  • Table 247. South America Rhodiola Root, by Country USD Million (2025-2030)
  • Table 248. South America Rhodiola Root, by Application USD Million (2025-2030)
  • Table 249. South America Rhodiola Root, by End User USD Million (2025-2030)
  • Table 250. South America Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 251. South America Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 252. Brazil Rhodiola Root, by Application USD Million (2025-2030)
  • Table 253. Brazil Rhodiola Root, by End User USD Million (2025-2030)
  • Table 254. Brazil Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 255. Brazil Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 256. Argentina Rhodiola Root, by Application USD Million (2025-2030)
  • Table 257. Argentina Rhodiola Root, by End User USD Million (2025-2030)
  • Table 258. Argentina Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 259. Argentina Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 260. Rest of South America Rhodiola Root, by Application USD Million (2025-2030)
  • Table 261. Rest of South America Rhodiola Root, by End User USD Million (2025-2030)
  • Table 262. Rest of South America Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 263. Rest of South America Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 264. Asia Pacific Rhodiola Root, by Country USD Million (2025-2030)
  • Table 265. Asia Pacific Rhodiola Root, by Application USD Million (2025-2030)
  • Table 266. Asia Pacific Rhodiola Root, by End User USD Million (2025-2030)
  • Table 267. Asia Pacific Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 268. Asia Pacific Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 269. China Rhodiola Root, by Application USD Million (2025-2030)
  • Table 270. China Rhodiola Root, by End User USD Million (2025-2030)
  • Table 271. China Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 272. China Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 273. Japan Rhodiola Root, by Application USD Million (2025-2030)
  • Table 274. Japan Rhodiola Root, by End User USD Million (2025-2030)
  • Table 275. Japan Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 276. Japan Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 277. India Rhodiola Root, by Application USD Million (2025-2030)
  • Table 278. India Rhodiola Root, by End User USD Million (2025-2030)
  • Table 279. India Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 280. India Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 281. South Korea Rhodiola Root, by Application USD Million (2025-2030)
  • Table 282. South Korea Rhodiola Root, by End User USD Million (2025-2030)
  • Table 283. South Korea Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 284. South Korea Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 285. Taiwan Rhodiola Root, by Application USD Million (2025-2030)
  • Table 286. Taiwan Rhodiola Root, by End User USD Million (2025-2030)
  • Table 287. Taiwan Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 288. Taiwan Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 289. Australia Rhodiola Root, by Application USD Million (2025-2030)
  • Table 290. Australia Rhodiola Root, by End User USD Million (2025-2030)
  • Table 291. Australia Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 292. Australia Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 293. Rest of Asia-Pacific Rhodiola Root, by Application USD Million (2025-2030)
  • Table 294. Rest of Asia-Pacific Rhodiola Root, by End User USD Million (2025-2030)
  • Table 295. Rest of Asia-Pacific Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 296. Rest of Asia-Pacific Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 297. Europe Rhodiola Root, by Country USD Million (2025-2030)
  • Table 298. Europe Rhodiola Root, by Application USD Million (2025-2030)
  • Table 299. Europe Rhodiola Root, by End User USD Million (2025-2030)
  • Table 300. Europe Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 301. Europe Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 302. Germany Rhodiola Root, by Application USD Million (2025-2030)
  • Table 303. Germany Rhodiola Root, by End User USD Million (2025-2030)
  • Table 304. Germany Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 305. Germany Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 306. France Rhodiola Root, by Application USD Million (2025-2030)
  • Table 307. France Rhodiola Root, by End User USD Million (2025-2030)
  • Table 308. France Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 309. France Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 310. Italy Rhodiola Root, by Application USD Million (2025-2030)
  • Table 311. Italy Rhodiola Root, by End User USD Million (2025-2030)
  • Table 312. Italy Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 313. Italy Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 314. United Kingdom Rhodiola Root, by Application USD Million (2025-2030)
  • Table 315. United Kingdom Rhodiola Root, by End User USD Million (2025-2030)
  • Table 316. United Kingdom Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 317. United Kingdom Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 318. Netherlands Rhodiola Root, by Application USD Million (2025-2030)
  • Table 319. Netherlands Rhodiola Root, by End User USD Million (2025-2030)
  • Table 320. Netherlands Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 321. Netherlands Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 322. Rest of Europe Rhodiola Root, by Application USD Million (2025-2030)
  • Table 323. Rest of Europe Rhodiola Root, by End User USD Million (2025-2030)
  • Table 324. Rest of Europe Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 325. Rest of Europe Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 326. MEA Rhodiola Root, by Country USD Million (2025-2030)
  • Table 327. MEA Rhodiola Root, by Application USD Million (2025-2030)
  • Table 328. MEA Rhodiola Root, by End User USD Million (2025-2030)
  • Table 329. MEA Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 330. MEA Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 331. Middle East Rhodiola Root, by Application USD Million (2025-2030)
  • Table 332. Middle East Rhodiola Root, by End User USD Million (2025-2030)
  • Table 333. Middle East Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 334. Middle East Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 335. Africa Rhodiola Root, by Application USD Million (2025-2030)
  • Table 336. Africa Rhodiola Root, by End User USD Million (2025-2030)
  • Table 337. Africa Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 338. Africa Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 339. North America Rhodiola Root, by Country USD Million (2025-2030)
  • Table 340. North America Rhodiola Root, by Application USD Million (2025-2030)
  • Table 341. North America Rhodiola Root, by End User USD Million (2025-2030)
  • Table 342. North America Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 343. North America Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 344. United States Rhodiola Root, by Application USD Million (2025-2030)
  • Table 345. United States Rhodiola Root, by End User USD Million (2025-2030)
  • Table 346. United States Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 347. United States Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 348. Canada Rhodiola Root, by Application USD Million (2025-2030)
  • Table 349. Canada Rhodiola Root, by End User USD Million (2025-2030)
  • Table 350. Canada Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 351. Canada Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 352. Mexico Rhodiola Root, by Application USD Million (2025-2030)
  • Table 353. Mexico Rhodiola Root, by End User USD Million (2025-2030)
  • Table 354. Mexico Rhodiola Root, by Nature USD Million (2025-2030)
  • Table 355. Mexico Rhodiola Root, by Dosage Form USD Million (2025-2030)
  • Table 356. Rhodiola Root Sales: by Application(Tons)
  • Table 357. Rhodiola Root Sales Altitude Sickness , by Region Tons (2025-2030)
  • Table 358. Rhodiola Root Sales Bladder Cancer , by Region Tons (2025-2030)
  • Table 359. Rhodiola Root Sales Depression , by Region Tons (2025-2030)
  • Table 360. Rhodiola Root Sales Fatigue , by Region Tons (2025-2030)
  • Table 361. Rhodiola Root Sales Other Applications , by Region Tons (2025-2030)
  • Table 362. South America Rhodiola Root Sales, by Country Tons (2025-2030)
  • Table 363. South America Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 364. South America Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 365. South America Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 366. South America Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 367. Brazil Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 368. Brazil Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 369. Brazil Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 370. Brazil Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 371. Argentina Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 372. Argentina Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 373. Argentina Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 374. Argentina Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 375. Rest of South America Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 376. Rest of South America Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 377. Rest of South America Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 378. Rest of South America Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 379. Asia Pacific Rhodiola Root Sales, by Country Tons (2025-2030)
  • Table 380. Asia Pacific Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 381. Asia Pacific Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 382. Asia Pacific Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 383. Asia Pacific Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 384. China Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 385. China Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 386. China Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 387. China Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 388. Japan Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 389. Japan Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 390. Japan Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 391. Japan Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 392. India Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 393. India Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 394. India Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 395. India Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 396. South Korea Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 397. South Korea Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 398. South Korea Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 399. South Korea Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 400. Taiwan Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 401. Taiwan Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 402. Taiwan Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 403. Taiwan Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 404. Australia Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 405. Australia Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 406. Australia Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 407. Australia Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 408. Rest of Asia-Pacific Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 409. Rest of Asia-Pacific Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 410. Rest of Asia-Pacific Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 411. Rest of Asia-Pacific Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 412. Europe Rhodiola Root Sales, by Country Tons (2025-2030)
  • Table 413. Europe Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 414. Europe Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 415. Europe Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 416. Europe Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 417. Germany Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 418. Germany Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 419. Germany Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 420. Germany Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 421. France Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 422. France Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 423. France Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 424. France Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 425. Italy Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 426. Italy Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 427. Italy Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 428. Italy Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 429. United Kingdom Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 430. United Kingdom Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 431. United Kingdom Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 432. United Kingdom Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 433. Netherlands Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 434. Netherlands Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 435. Netherlands Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 436. Netherlands Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 437. Rest of Europe Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 438. Rest of Europe Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 439. Rest of Europe Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 440. Rest of Europe Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 441. MEA Rhodiola Root Sales, by Country Tons (2025-2030)
  • Table 442. MEA Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 443. MEA Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 444. MEA Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 445. MEA Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 446. Middle East Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 447. Middle East Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 448. Middle East Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 449. Middle East Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 450. Africa Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 451. Africa Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 452. Africa Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 453. Africa Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 454. North America Rhodiola Root Sales, by Country Tons (2025-2030)
  • Table 455. North America Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 456. North America Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 457. North America Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 458. North America Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 459. United States Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 460. United States Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 461. United States Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 462. United States Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 463. Canada Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 464. Canada Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 465. Canada Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 466. Canada Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 467. Mexico Rhodiola Root Sales, by Application Tons (2025-2030)
  • Table 468. Mexico Rhodiola Root Sales, by End User Tons (2025-2030)
  • Table 469. Mexico Rhodiola Root Sales, by Nature Tons (2025-2030)
  • Table 470. Mexico Rhodiola Root Sales, by Dosage Form Tons (2025-2030)
  • Table 471. Research Programs/Design for This Report
  • Table 472. Key Data Information from Secondary Sources
  • Table 473. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Rhodiola Root: by Application USD Million (2018-2023)
  • Figure 5. South America Rhodiola Root Share (%), by Country
  • Figure 6. Asia Pacific Rhodiola Root Share (%), by Country
  • Figure 7. Europe Rhodiola Root Share (%), by Country
  • Figure 8. MEA Rhodiola Root Share (%), by Country
  • Figure 9. North America Rhodiola Root Share (%), by Country
  • Figure 10. Global Rhodiola Root: by Application Tons (2018-2023)
  • Figure 11. South America Rhodiola Root Share (%), by Country
  • Figure 12. Asia Pacific Rhodiola Root Share (%), by Country
  • Figure 13. Europe Rhodiola Root Share (%), by Country
  • Figure 14. MEA Rhodiola Root Share (%), by Country
  • Figure 15. North America Rhodiola Root Share (%), by Country
  • Figure 16. Global Rhodiola Root share by Players 2023 (%)
  • Figure 17. Global Rhodiola Root share by Players (Top 3) 2023(%)
  • Figure 18. Global Rhodiola Root share by Players (Top 5) 2023(%)
  • Figure 19. BCG Matrix for key Companies
  • Figure 20. NutraChamps Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 21. NutraChamps Inc. (Canada) Revenue: by Geography 2023
  • Figure 22. Organic Herb Inc. (China) Revenue, Net Income and Gross profit
  • Figure 23. Organic Herb Inc. (China) Revenue: by Geography 2023
  • Figure 24. Amax NutraSource (United States) Revenue, Net Income and Gross profit
  • Figure 25. Amax NutraSource (United States) Revenue: by Geography 2023
  • Figure 26. Xian Yuensun Biological Technology Co.,Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 27. Xian Yuensun Biological Technology Co.,Ltd. (China) Revenue: by Geography 2023
  • Figure 28. PLT Health Solutions, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. PLT Health Solutions, Inc. (United States) Revenue: by Geography 2023
  • Figure 30. Xi’an Greena Biotech Co.,Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 31. Xi’an Greena Biotech Co.,Ltd. (China) Revenue: by Geography 2023
  • Figure 32. Swanson Health Products (United States) Revenue, Net Income and Gross profit
  • Figure 33. Swanson Health Products (United States) Revenue: by Geography 2023
  • Figure 34. Planetary Herbals (United States) Revenue, Net Income and Gross profit
  • Figure 35. Planetary Herbals (United States) Revenue: by Geography 2023
  • Figure 36. Gaia Herbs, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 37. Gaia Herbs, LLC (United States) Revenue: by Geography 2023
  • Figure 38. Nutracraft (United States) Revenue, Net Income and Gross profit
  • Figure 39. Nutracraft (United States) Revenue: by Geography 2023
  • Figure 40. Global Rhodiola Root: by Application USD Million (2025-2030)
  • Figure 41. South America Rhodiola Root Share (%), by Country
  • Figure 42. Asia Pacific Rhodiola Root Share (%), by Country
  • Figure 43. Europe Rhodiola Root Share (%), by Country
  • Figure 44. MEA Rhodiola Root Share (%), by Country
  • Figure 45. North America Rhodiola Root Share (%), by Country
  • Figure 46. Global Rhodiola Root: by Application Tons (2025-2030)
  • Figure 47. South America Rhodiola Root Share (%), by Country
  • Figure 48. Asia Pacific Rhodiola Root Share (%), by Country
  • Figure 49. Europe Rhodiola Root Share (%), by Country
  • Figure 50. MEA Rhodiola Root Share (%), by Country
  • Figure 51. North America Rhodiola Root Share (%), by Country
List of companies from research coverage that are profiled in the study
  • NutraChamps Inc. (Canada)
  • Organic Herb Inc. (China)
  • Amax NutraSource (United States)
  • Xian Yuensun Biological Technology Co.,Ltd. (China)
  • PLT Health Solutions, Inc. (United States)
  • Xi’an Greena Biotech Co.,Ltd. (China)
  • Swanson Health Products (United States)
  • Planetary Herbals (United States)
  • Gaia Herbs, LLC (United States)
  • Nutracraft (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 240 Pages 90 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Rhodiola Root Market Quantitative research analysis
Global Rhodiola Root Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as NutraChamps Inc. (Canada), Organic Herb Inc. (China), Amax NutraSource (United States), Xian Yuensun Biological Technology Co.,Ltd. (China), PLT Health Solutions, Inc. (United States), Xi’an Greena Biotech Co.,Ltd. (China), Swanson Health Products (United States), Planetary Herbals (United States), Gaia Herbs, LLC (United States) and Nutracraft (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Use of Rhodiola Root in Asian Countries" is seen as one of major influencing trends for Rhodiola Root Market during projected period 2023-2030.
The Rhodiola Root market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Rhodiola Root Market Report?

Have a Query? Click Here

Other Related Reports

Dairy Fermentation Starter Comprehensive Study by Type (Mesophilic, Thermophilic, Probiotics), Application (Yoghurt, Cheese, Cream, Buttermilk, Others) Players and Region - Global Market Outlook to 2...
$ 3500
Citrus Based Dietary Fibers Comprehensive Study by Type (Pectin, Hemicellulose, Cellulose), Application (Bakery, Dairy, Fruit Beverages, Fruit Preserves, Nutrition Supplement, Others), Distribution C...
$ 3650
Frozen Finger Chips Comprehensive Study by Type (White Potato Chips, Sweet Potato Chips), Application (Household, Commercial), Packaging (Bagged, Canned), Sales Channel (Online, Offline {Hypermarkets...
$ 3350
Synthetic Food Comprehensive Study by Type (Colour, Enzymes, Hydrocolloids, Flavour & Fragrances, Antioxidants, Emulsifiers, Fat Replacers), Application (Beverages, Dairy & Frozen Products, Bakery & ...
$ 3750
Dehydrated Backpacking and Camping Food Comprehensive Study by Type (Freeze Dried, Air/Solar Dried), Category (Bakery Items, Meat, Fish & Poultry, Snacks, Dry Fruits and Nuts, Desserts, Soups & Pasta...
$ 3800
Food Protein Ingredient Comprehensive Study by Type (Plant-Based, Animal Based), Application (Sports nutrition, Clinical Nutrition, Infant Nutrition, Fortified Foods, Functional Food and Beverages), ...
$ 3350